Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

PCO₂ Gap and Lactate as Predictors of POCD After Cardiac Surgery

23. September 2026 aktualisiert von: Ain Shams University

Intraoperative PCO₂ Gap and Lactate Levels as Early Predictors of Postoperative Cognitive Dysfunction in Elderly Patients Undergoing Cardiac Surgery With Cardiopulmonary Bypass

This prospective observational study aims to evaluate whether intraoperative venous-to-arterial carbon dioxide partial pressure difference (PCO₂ gap) and arterial lactate levels can serve as early predictors of postoperative cognitive dysfunction (POCD) in elderly patients undergoing elective cardiac surgery with cardiopulmonary bypass. Intraoperative measurements of PCO₂ gap and lactate will be correlated with perioperative cognitive outcomes assessed using the Montreal Cognitive Assessment (MoCA) and postoperative delirium screening using the Confusion Assessment Method for the ICU (CAM-ICU).

Studienübersicht

Status

Noch keine Rekrutierung

Bedingungen

Detaillierte Beschreibung

This prospective observational cohort study will be conducted at El-Demerdash Hospital, Ain Shams University. Patients aged 65 years and older undergoing elective cardiac surgery with cardiopulmonary bypass will be enrolled. Serial measurements of the PCO₂ gap and arterial lactate will be obtained before induction, during CPB, at the end of CPB, 30 minutes after weaning from CPB, and immediately postoperatively. Cognitive function will be evaluated preoperatively and one month after surgery using the Montreal Cognitive Assessment (MoCA). Postoperative delirium will be assessed daily during ICU stay using CAM-ICU. The study will investigate the predictive value of intraoperative PCO₂ gap and lactate levels for postoperative cognitive dysfunction and determine potential cutoff values associated with cognitive decline.

Studientyp

Beobachtungs

Einschreibung (Geschätzt)

185

Kontakte und Standorte

Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.

Studienkontakt

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

65 Jahre und älter (Älterer Erwachsener)

Akzeptiert gesunde Freiwillige

Nein

Studienberechtigte Geschlechter

Alle

Probenahmeverfahren

Nicht-Wahrscheinlichkeitsprobe

Studienpopulation

Elderly patients (65 years or older) undergoing elective cardiac surgery with cardiopulmonary bypass at El-Demerdash Hospital, Ain Shams University, Cairo, Egypt. Eligible participants will undergo routine perioperative management with serial intraoperative PCO₂ gap and arterial lactate measurements and perioperative cognitive assessment according to the study protocol.

Beschreibung

Inclusion Criteria:

  • Age ≥65 years.
  • Undergoing elective cardiac surgery with cardiopulmonary bypass (e.g., coronary artery bypass grafting or valve surgery).
  • American Society of Anesthesiologists (ASA) Physical Status III.
  • Able to provide written informed consent.

Exclusion Criteria:

  • Refusal or inability to provide written informed consent.
  • Pre-existing neurological disorders (e.g., Alzheimer's disease, Parkinson's disease, or stroke with residual neurological deficits).
  • Severe psychiatric disorders requiring active treatment.
  • History of drug or alcohol abuse.
  • Emergency cardiac surgery.
  • Significant visual or hearing impairment interfering with cognitive testing.
  • Inability to complete preoperative cognitive assessment.
  • Preoperative dementia (MoCA score <20).
  • Significant pulmonary disease (e.g., COPD or lung cancer).
  • Patients meeting the protocol-defined intraoperative or postoperative exclusion criteria.

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

  • Beobachtungsmodelle: COHORT
  • Zeitperspektiven: PROSPECTIVE

Kohorten und Interventionen

Gruppe / Kohorte
Elderly Patients Undergoing Elective Cardiac Surgery with Cardiopulmonary Bypass

Patients aged 65 years or older undergoing elective cardiac surgery with cardiopulmonary bypass. Participants will undergo serial intraoperative measurements of the venous-to-arterial carbon dioxide partial pressure difference (PCO₂ gap) and arterial lactate levels. Postoperative cognitive function will be assessed using the Montreal Cognitive Assessment (MoCA), and postoperative delirium will be screened using the Confusion Assessment Method for the ICU (CAM-ICU).

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Predictive Value of Intraoperative PCO₂ Gap and Arterial Lactate Levels for Postoperative Cognitive Dysfunction (POCD
Zeitfenster: Baseline (preoperative) and 1 month postoperatively

To evaluate whether intraoperative venous-to-arterial carbon dioxide partial pressure difference (PCO₂ gap) and arterial lactate levels predict postoperative cognitive dysfunction in elderly patients undergoing elective cardiac surgery with cardiopulmonary bypass. POCD will be assessed by changes in Montreal Cognitive Assessment (MoCA) scores from the preoperative baseline to 1 month postoperatively.

Baseline (preoperative) and 1 month postoperatively

Sekundäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Early Postoperative Delirium Assessed by the Confusion Assessment Method for the ICU (CAM-ICU)
Zeitfenster: Daily during the first 5 postoperative days or until ICU discharge, whichever occurs first

To determine the occurrence of early postoperative delirium using the Confusion Assessment Method for the ICU (CAM-ICU). CAM-ICU is a dichotomous assessment (positive or negative), where a positive result indicates the presence of delirium

Daily during the first 5 postoperative days or until ICU discharge, whichever occurs first
Determination of Cutoff Values for Intraoperative PCO₂ Gap and Arterial Lactate Levels Predictive of POCD
Zeitfenster: 1 month postoperative

To identify optimal cutoff values for intraoperative PCO₂ gap and arterial lactate levels associated with postoperative cognitive dysfunction in elderly patients undergoing cardiac surgery with cardiopulmonary bypass.The PCO₂ gap will be measured in mmHg, and arterial lactate concentration will be measured in mmol/L.

1 month postoperative
Correlation of (CAM - ICU) to MoCA for prediction of cognitive impairmentat 5 days post operative
Zeitfenster: CAM-ICU: Daily during the first 5 postoperative days; MoCA: baseline preoperatively and 1 month postoperatively

To evaluate the correlation between postoperative delirium assessed by the Confusion Assessment Method for the ICU (CAM-ICU) and postoperative cognitive function assessed by the Montreal Cognitive Assessment (MoCA).CAM-ICU will be recorded as a dichotomous result (positive or negative), with a positive result indicating the presence of delirium. MoCA will be recorded as a total score ranging from 0 to 30, with higher scores indicating better cognitive function

CAM-ICU: Daily during the first 5 postoperative days; MoCA: baseline preoperatively and 1 month postoperatively
Incidence of POCD at 1 month postoperatively, defined by a decline in MoCA scores from baseline in elderly cardiac patient.
Zeitfenster: Baseline (preoperative) and 1 month postoperatively

To determine the incidence of postoperative cognitive dysfunction, defined as a decline in MoCA score from the preoperative baseline, one month after cardiac surgery

Baseline (preoperative) and 1 month postoperatively
Duration of Mechanical Ventilation in Relation to Intraoperative PCO₂ Gap and Arterial Lactate Levels
Zeitfenster: Measured from the end of surgery until successful extubation (up to 30 days)

To evaluate the association between intraoperative PCO₂ gap and arterial lactate levels and the duration of mechanical ventilation following cardiac surgery with cardiopulmonary bypass. Duration of mechanical ventilation will be measured in hours from the end of surgery until successful extubation, as documented in the patient's medical and ventilator records.

Measured from the end of surgery until successful extubation (up to 30 days)
Duration of Intensive Care Unit Stay in Relation to Intraoperative PCO₂ Gap and Arterial Lactate Levels
Zeitfenster: From ICU admission after surgery until ICU discharge, up to 30 days

To evaluate the association between intraoperative PCO₂ gap and arterial lactate levels and the duration of intensive care unit (ICU) stay following cardiac surgery with cardiopulmonary bypass. ICU stay will be measured in days from ICU admission after surgery until ICU discharge, as documented in the patient's medical records.

From ICU admission after surgery until ICU discharge, up to 30 days
Duration of Hospital Stay in Relation to Intraoperative PCO₂ Gap and Arterial Lactate Levels
Zeitfenster: From the end of surgery until hospital discharge, up to 30 days

To evaluate the association between intraoperative PCO₂ gap and arterial lactate levels and the duration of hospital stay following cardiac surgery with cardiopulmonary bypass. Hospital stay will be measured in days from the end of surgery until hospital discharge, as documented in the patient's medical records.

From the end of surgery until hospital discharge, up to 30 days

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Sponsor

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn (Geschätzt)

1. Dezember 2026

Primärer Abschluss (Geschätzt)

1. Mai 2028

Studienabschluss (Geschätzt)

1. August 2028

Studienanmeldedaten

Zuerst eingereicht

29. Juni 2026

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

23. September 2026

Zuerst gepostet (Tatsächlich)

25. September 2026

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Tatsächlich)

25. September 2026

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

23. September 2026

Zuletzt verifiziert

1. Juni 2026

Mehr Informationen

Begriffe im Zusammenhang mit dieser Studie

Andere Studien-ID-Nummern

  • FMASU MD309/2025

Plan für individuelle Teilnehmerdaten (IPD)

Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?

NEIN

Arzneimittel- und Geräteinformationen, Studienunterlagen

Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt

Nein

Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt

Nein

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .